How are RYTM bear put spread max profit and max loss calculated?

Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit. For the RYTM bear put spread priced from the end-of-day chain at a 30-day expiry (ATM IV 81.90%), the computed maximum profit is $240.00 per contract and the computed maximum loss is -$260.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a RYTM bear put spread?

The breakeven for the RYTM bear put spread priced on this page is roughly $87.40 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current RYTM market-implied 1-standard-deviation expected move is approximately 23.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current RYTM implied volatility affect this bear put spread?

RYTM ATM IV is at 81.90% with IV rank near 37.64%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

RYTM Bear Put Spread Strategy

RYTM (Rhythm Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is also developing setmelanotide, which is in Phase II clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, Smith-Magenis syndrome obesity, POMC epigenetic disorders, and other MC4R disorders. Rhythm Pharmaceuticals, Inc. has a collaborative research agreement with the Clinical Registry Investigating Bardet-Biedl Syndrome. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

RYTM (Rhythm Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $6.42B, a beta of 1.94 versus the broader market, a 52-week range of 57.2-122.2, average daily share volume of 873K, a public-listing history dating back to 2017, approximately 283 full-time employees. These structural characteristics shape how RYTM stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.94 indicates RYTM has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a bear put spread on RYTM?

A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width.

Current RYTM snapshot

As of May 15, 2026, spot at $90.66, ATM IV 81.90%, IV rank 37.64%, expected move 23.48%. The bear put spread on RYTM below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this bear put spread structure on RYTM specifically: RYTM IV at 81.90% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 23.48% (roughly $21.29 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated RYTM expiries trade a higher absolute premium for lower per-day decay. Position sizing on RYTM should anchor to the underlying notional of $90.66 per share and to the trader's directional view on RYTM stock.

RYTM bear put spread setup

The RYTM bear put spread below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With RYTM near $90.66, the first option leg uses a $90.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed RYTM chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 RYTM shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Put	$90.00	$10.20
Sell 1	Put	$85.00	$7.60

RYTM bear put spread risk and reward

Net Premium / Debit: -$260.00
Max Profit (per contract): $240.00
Max Loss (per contract): -$260.00
Breakeven(s): $87.40
Risk / Reward Ratio: 0.923

Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit.

RYTM bear put spread payoff curve

Modeled P&L at expiration across a range of underlying prices for the bear put spread on RYTM. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$240.00
$20.05	-77.9%	+$240.00
$40.10	-55.8%	+$240.00
$60.14	-33.7%	+$240.00
$80.19	-11.6%	+$240.00
$100.23	+10.6%	-$260.00
$120.28	+32.7%	-$260.00
$140.32	+54.8%	-$260.00
$160.36	+76.9%	-$260.00
$180.41	+99.0%	-$260.00

When traders use bear put spread on RYTM

Bear put spreads on RYTM reduce the cost of a bearish RYTM stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.

RYTM thesis for this bear put spread

The market-implied 1-standard-deviation range for RYTM extends from approximately $69.37 on the downside to $111.95 on the upside. A RYTM bear put spread caps both the risk and the reward of a bearish position; relative to an outright long put on RYTM, the spread reduces the cost basis but limits the maximum profit to the strike width minus net debit. Current RYTM IV rank near 37.64% is mid-range against its 1-year distribution, so the IV signal is neutral; the bear put spread thesis on RYTM should anchor more to the directional view and the expected-move geometry. As a Healthcare name, RYTM options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to RYTM-specific events.

RYTM bear put spread positions are structurally moderately bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. RYTM positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move RYTM alongside the broader basket even when RYTM-specific fundamentals are unchanged. Long-premium structures like a bear put spread on RYTM are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current RYTM chain quotes before placing a trade.

Frequently asked questions

What is a bear put spread on RYTM?: A bear put spread on RYTM is the bear put spread strategy applied to RYTM (stock). The strategy is structurally moderately bearish: A bear put spread buys an at-the-money put and sells an out-of-the-money put at a lower strike for defined risk and defined reward bounded by the strike width. With RYTM stock trading near $90.66, the strikes shown on this page are snapped to the nearest listed RYTM chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are RYTM bear put spread max profit and max loss calculated?: Max profit equals strike width minus net debit times 100; max loss equals net debit times 100. Breakeven is long-put strike minus net debit. For the RYTM bear put spread priced from the end-of-day chain at a 30-day expiry (ATM IV 81.90%), the computed maximum profit is $240.00 per contract and the computed maximum loss is -$260.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a RYTM bear put spread?: The breakeven for the RYTM bear put spread priced on this page is roughly $87.40 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current RYTM market-implied 1-standard-deviation expected move is approximately 23.48%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a bear put spread on RYTM?: Bear put spreads on RYTM reduce the cost of a bearish RYTM stock position by selling a lower-strike put; suited to moderate-decline theses where price reaches but does not vastly exceed the short strike.
How does current RYTM implied volatility affect this bear put spread?: RYTM ATM IV is at 81.90% with IV rank near 37.64%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.